<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Standard treatment of <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme consists of postoperative radiochemotherapy with temozolomide, followed by a 6-month chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Serious hematologic complications are rarely reported </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT AND RESULTS: The authors present the case of a 61-year-old female patient with <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme treated with external-beam radiation therapy and concomitant temozolomide </plain></SENT>
<SENT sid="3" pm="."><plain>After completion of treatment, the patient developed symptoms of serious <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> that eventually led to <z:hpo ids='HP_0011420'>death</z:hpo> due to prolonged neutro- and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> followed by infectious complications </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Lethal complications following temozolomide are, per se, extremely rare, however, a total of four other cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> have been reported in the literature so far </plain></SENT>
</text></document>